Silencing of FTO results in up-regulation of TFPI-2 expression (i.e. through restoring m6A/YTHDF1 mediated stability of TFPI-2 mRNA), and inhibits PC proliferation, invasion in vitro, and tumor growth in vivo [121]. The gene discussed is TFPI2; the disease is pachyonychia congenita.